Involvement of Smad3 in upregulated inflammatory responses has been supported by several recent studies using such diverse models as ischemic nephropathy, hypertensive renal and cardiac remodeling, healing myocardial infarct, and orthotopic heart transplant rejection (21, 78, 85–87). This evidence concerns the gene SMAD3 and myocardial infarction.